Subglottic secretion suction for preventing ventilator-associated pneumonia: an updated meta-analysis and trial...

Area of Science:

• Critical Care Medicine
• Respiratory Medicine
• Infectious Disease Prevention

Background:

• The efficacy of subglottic secretion suction in preventing ventilator-associated pneumonia (VAP) requires further clarification.
• VAP remains a significant concern in mechanically ventilated patients, necessitating effective preventive strategies.

Purpose of the Study:

• To systematically evaluate the effectiveness of subglottic secretion suction in preventing VAP.
• To assess the impact of subglottic secretion suction on VAP incidence, mortality, and ventilation duration.

Main Methods:

• A meta-analysis of randomized controlled trials (RCTs) was conducted, searching major databases up to March 2016.
• Twenty RCTs involving 3544 adult patients on mechanical ventilation were included.
• The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework was used to assess evidence quality.

Main Results:

• Subglottic secretion suction significantly reduced VAP incidence (RR 0.55, 95% CI 0.48-0.63) across all included trials.
• The intervention was associated with a reduction in early-onset VAP and the duration of mechanical ventilation.
• No significant differences were observed in late-onset VAP, ICU mortality, hospital mortality, or ICU length of stay.

Conclusions:

• Subglottic secretion suction is a recommended intervention for preventing VAP and reducing mechanical ventilation duration.
• The procedure is particularly beneficial for patients at high risk of early-onset VAP.
• While effective for VAP prevention, subglottic secretion suction did not demonstrate a significant reduction in patient mortality or ICU stay.